Epix to cut work force, narrow research focus

10/23/2008 | AuntMinnie.com (free registration)

Epix Pharmaceuticals has announced plans to slash its work force by 23% and reduce its research and development focus in order to cut costs. The contrast-agent developer said it will concentrate on developing PRX-03140 for Alzheimer's disease and PRX-08066 for chronic obstructive pulmonary disease but will continue plans to market its Vasovist MRI contrast agent.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI